Insights
Our point of view on the pharmacy channel, what actually happens after the rep leaves, what verified execution changes, and how always-on brands win the counter. Short reads, written for people who own a number.
Around 5,800 community pharmacies sell your category. Your field team visits a fraction of them, on a cycle measured in weeks. Everywhere else, your brand is unbriefed, unmeasured and unmanaged. Here’s the arithmetic, and what to do about it.
Read the flagship piece →The field force is the biggest line in the P&L and the one asset a company would never trade. Its judgement is delivered in an hour, then waits six weeks.
Read →Consumer health devices have moved out of the clinic and into the home, and the data they produce now shapes treatment. Acquisition is counted. Activation is not.
Read →People, a clear process, and the Portal behind them. Multiply that across a network and many campaigns at once, and that is where the real value to your business shows up.
Read →Wobblers, jigglers and gondola end creative are designed, approved and printed long before anyone at the counter sees them. CampaignINSIGHT puts the creative in front of hundreds of pharmacists and pharmacy assistants in days, at a fraction of the cost of traditional research.
Read →Most channel investment is judged on what was promised. Time-stamped, human-checked validation turns pharmacy from a leap of faith into a line item you can defend.
Read →Launch spikes decay. Shelf standards drift. Recommendation fades. The brands compounding in pharmacy are the ones that never leave the store. Here’s the operating rhythm.
Read →Pharmacy teams are among the most trained people in retail. Knowing your brand is not recommending it. What turns a briefed team into a recommending one, and why the answer is not more education.
Read →The catalogue win is the easy part. Getting hundreds of pharmacies to build the display, brief staff and hold execution across a four-week window is the job nobody owns, and it never reaches the slide.
Read →Up to 500,000 Australians live with undiagnosed type 2 diabetes. They already see a pharmacist more often than a GP. The most under-used screening network in the country is open right now.
Read →A rep is one person with a route, and a route has edges. When a store sits at the wrong point in the loop, who carries the objective the visit couldn't land, and reaches the pharmacies a field plan was never going to include?
Read →Up to 90% of kidney function can be lost before symptoms appear, and the people most at risk already collect their medicines at the counter every month. Earlier detection is an execution problem, not a clinical one.
Read →You have segmented your pharmacy stores by potential, banner and performance. But have you reviewed how each segment is actually serviced between visits? Targeting answers who, not how.
Read →A worked model comparing fully-loaded field visit costs against platform execution, with a template you can run on your own brand’s numbers.
Subscribe below to get it first.
